Echoiq Ltd Total Liabilities
Echoiq Ltd total liabilities. Based on the latest financial reports, Echoiq Ltd (EIQ) has total liabilities worth AU$718.61K AUD (≈ $508.46K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EIQ cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Echoiq Ltd (2010–2024)
Total liabilities of Echoiq Ltd from 2010 to 2024. This chart illustrates how Echoiq Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Echoiq Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Echoiq Ltd Competitors by Total Liabilities
The table below lists competitors of Echoiq Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BIDV Securities JSC
VN:BSI
|
Vietnam | ₫11.10 Trillion |
|
Servicios Corporativos Javer
MX:JAVER
|
Mexico | MX$6.28 Billion |
|
Asia Aviation Public Company Limited
F:55AA
|
Germany | €61.59 Billion |
|
Asia Polymer Corp
TW:1308
|
Taiwan | NT$1.51 Billion |
|
Fagerhult AB
ST:FAG
|
Sweden | Skr6.56 Billion |
|
Samyang Holdings
KO:000070
|
Korea | ₩2.59 Trillion |
|
NOCIL Limited
NSE:NOCIL
|
India | Rs3.37 Billion |
Liability Composition Analysis (2010–2024)
This chart breaks down Echoiq Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see EIQ asset base.
Liquidity & Leverage Metrics
Echoiq Ltd Total Liabilities Ratios Explained
Echoiq Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 18.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Echoiq Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Echoiq Ltd (2010–2024)
The table below shows the annual total liabilities of Echoiq Ltd from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$615.41K ≈ $435.44K |
-58.63% |
| 2023-12-31 | AU$1.49 Million ≈ $1.05 Million |
-50.43% |
| 2022-12-31 | AU$3.00 Million ≈ $2.12 Million |
+35.66% |
| 2021-12-31 | AU$2.21 Million ≈ $1.57 Million |
+101.62% |
| 2020-12-31 | AU$1.10 Million ≈ $776.31K |
+6.97% |
| 2019-12-31 | AU$1.03 Million ≈ $725.74K |
-23.50% |
| 2018-12-31 | AU$1.34 Million ≈ $948.70K |
+43.14% |
| 2017-12-31 | AU$936.69K ≈ $662.77K |
+56.33% |
| 2016-12-31 | AU$599.18K ≈ $423.96K |
-65.08% |
| 2015-12-31 | AU$1.72 Million ≈ $1.21 Million |
+985.35% |
| 2014-12-31 | AU$158.09K ≈ $111.86K |
-3.91% |
| 2013-12-31 | AU$164.52K ≈ $116.41K |
+25.27% |
| 2012-12-31 | AU$131.33K ≈ $92.93K |
-32.19% |
| 2011-12-31 | AU$193.68K ≈ $137.04K |
-34.97% |
| 2010-12-31 | AU$297.81K ≈ $210.72K |
-- |
About Echoiq Ltd
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to E… Read more